Product Images Tri-lo-mili

The above text describes the risk of breast cancer associated with combined oral contraceptive use from various studies conducted between 2002 and 2017. It includes details of the studies such as the NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses' Health Study I, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study, along with the effect estimate (OR/RR) data.*

This appears to be a chart or list of various birth control methods and their effectiveness rates in preventing pregnancy. Some examples listed include intrauterine devices, birth control pills, condoms, and the withdrawal method. The chart also includes the pregnancy rates per 100 women using each method.*

Tri-Lo-Mili is a prescription-only medicine sold in packages of 28 tablets to be taken for 28 days. The product contains 0.18mg/0.025mg hormones and is intended for regular contraception in women. The tablets are manufactured by Aurobindo Pharma Limited based in Hyderabad, India, and retailed under the label of Proficient Rx LP in Thousand Oaks, CA. The medicine should be stored at room temperature between 20°-25°C and kept out of the reach of children. The package includes an insert with detailed instructions for use. The product is identifiable via NDC 71205-746-28, product ID ST074628, lot number 00000, and SN# MASTER. The expiration date is not available.*

Ethinyl Estradiol is a medication commonly used as a form of birth control. It is a synthetic form of the hormone estrogen and is usually taken in combination with a progestin. It works by preventing ovulation and thickening cervical mucus to make it harder for sperm to reach the egg. It is available in various forms, including pills, patches, and injections.*